Answers are grounded in this paper and cite their sources.
Translocator protein (TSPO, 18 kDa), previously known as peripheral-type benzodiazepine receptor, is an evolutionarily conserved membrane protein involved in various physiological processes and patho-physiological conditions. The endogeneous TSPO ligand is a polypeptide of 9 kDa, but dipeptides with biological activity have been previously synthesized and characterized. Herein, we synthesized a phenyl alanine derived ligand with a 19 F labelling which opens prospective for 19 F-MRI and potential 18 F-PET applications. We characterized the coexistence of two conformers that are not equally sensitive to the media used for membrane protein studies. Interaction studies with the recombinant mouse TSPO (mTSPO) in different membrane-mimicking environments are presented using 19 F NMR enabling structure/function characterizations. A change in the mTSPO environment from pure detergent to lipid/detergent mixture reveals different exchange rates between bound and free ligand forms. Competition experiments with the high-affinity drug ligand ( R )-PK 11195 suggests that phenyl alanine derived ligand binds in the same protein cavity. Highlights Fluor labelling of ligands easily reveals the presence of conformers Fluorinated phenyl alanine derived ligand interacts with TSPO Fluor NMR enables characterization of TSPO ligand interactions Fluor NMR facilitates exchange rate studies between free and bound ligand states Graphical Abstract
No takes yet. Share an insight, caveat, or question.
Duma et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: